NovaBridge Biosciences (NBP): Shareholders' Equity
Older than the company's other figures. The latest Shareholders' Equity is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
1.72B CNY
As of 2023-12-31
-32.7%
3-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2023-12-31 | 1.72B CNY | -41.0% | 2024-04-30, Balance as of period end |
| 2022-12-31 | 2.91B CNY | -36.2% | 2024-04-30, Balance as of period end |
| 2021-12-31 | 4.56B CNY | -19.0% | 2024-04-30, Balance as of period end |
| 2020-12-31 | 5.63B CNY | n/m | 2023-05-01, Balance as of period end |
| 2019-12-31 | -2.03B CNY | n/m | 2022-04-29, Balance as of period end |
| 2018-12-31 | -955.10M CNY | n/m | 2021-04-28, Balance as of period end |
| 2017-12-31 | -299.80M CNY | n/a | 2020-04-29, Balance as of period end |